Edition:
United Kingdom

MEI Pharma Inc (MEIP.OQ)

MEIP.OQ on NASDAQ Stock Exchange Capital Market

3.67USD
17 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.67
Open
$3.65
Day's High
$3.75
Day's Low
$3.64
Volume
38,190
Avg. Vol
94,435
52-wk High
$5.13
52-wk Low
$1.79

Chart for

About

MEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and PWT143. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the... (more)

Overall

Beta: 1.43
Market Cap(Mil.): $94.93
Shares Outstanding(Mil.): 36.94
Dividend: --
Yield (%): --

Financials

  MEIP.OQ Industry Sector
P/E (TTM): 38.43 85.68 32.76
EPS (TTM): 0.07 -- --
ROI: 5.77 1.78 14.61
ROE: 5.77 3.28 16.33

BRIEF-MEI Pharma And Helsinn Announce Positive Results In Myelodysplastic Syndrome Trial

* MEI PHARMA AND HELSINN GROUP ANNOUNCE SUCCESSFUL INTERIM ANALYSIS OF PRACINOSTAT/AZACITIDINE PHASE 2 COMBINATION STUDY IN HIGHER RISK MYELODYSPLASTIC SYNDROME (MDS) PATIENTS

31 May 2018

BRIEF-Growth Equity Opportunities Fund V LLC Reports 9.99 Pct Stake In MEI Pharma Inc

* GROWTH EQUITY OPPORTUNITIES FUND V LLC REPORTS 9.99 PERCENT STAKE IN MEI PHARMA INC AS OF MAY 16 - SEC FILING Source text: (https://bit.ly/2IHP4lE) Further company coverage:

23 May 2018

BRIEF-MEI Pharma Q3 Loss Per Share $0.16

* Q3 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S

09 May 2018

BRIEF-Mei Pharma Inc says ‍On Feb 22, Board Voted To Increase Size Of Board By One Seat

* MEI PHARMA INC - ‍ON FEBRUARY 22, 2018, BOARD OF CO VOTED TO INCREASE SIZE OF BOARD BY ONE SEAT -SEC FILING​ Source text - (http://bit.ly/2EUshBn) Further company coverage:

26 Feb 2018

Earnings vs. Estimates